GRDX

Healthcare Biotechnology

GridAI Technologies Corp.

$4.17

+0.34 +8.88% today

Price History

Not enough data

Key Stats

Market Cap

29.74M

Avg Volume

99,881

EPS

-$5.65

52W High

$6.93

52W Low

$1.87

Div. Yield

0.0%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

Net Margin 0.0%

EBITDA Margin 0.0%

About

GridAI Technologies Corp., together with its subsidiaries, designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. It also develops Adrulipase, a recombinant lipase enzyme program for the treatment of exocrine pancreatic insufficiency. The company is based in Edinburgh, United Kingdom.